RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 Ranibizumab 0.5 mg Safe and Effective for Treatment of DME
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 43
SP 8
OP 9
DO 10.1177/155989771443003
UL http://mdc.sagepub.com/content/14/43/8.abstract
AB This article discusses a post hoc analysis of 5 studies of the humanized monoclonal antibody ranibizumab directed against vascular endothelial growth factor-A in the treatment of diabetic macular edema. The analysis focuses on the arterial thromboembolic events associated with ranibizumab that have been reported in controlled clinical trials.